AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
IND application filed for lung and colorectal cancer vaccine candidate.
2003 JAN 8 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) announced that it has filed an investigational new drug application, or IND, with the United States Food and Drug Administration (FDA), for a multiepitope vaccine for the treatment of lung and colorectal cancer.
Pending FDA review, two separate phase I/II trials will be initiated, one trial for each cancer indication, and will involve an aggregate of approximately 25 patients who have had surgery to remove the majority of the cancer cells. These patients generally have normal immune system function.
The vaccine candidate, EP-2101, will include proprietary, native epitopes as well as a number of modified, or analog, epitopes which are ...
- Epimmune Files Investigational New Drug Application for Lung and Colorectal...
- Press release article from: PR Newswire December 9, 2002 700+ words
...the treatment of lung and colorectal cancer. Pending FDA review, two...immune system function. The vaccine candidate, EP-2101, will include...clinical trials for lung and colorectal cancer, the regulatory approval...
- IND application filed for lung and colorectal cancer vaccine candidate.
- Newspaper article from: Biotech Week January 8, 2003 700+ words
...for a multiepitope vaccine for the treatment of lung and colorectal cancer. Pending FDA review, two separate phase I/II trials...patients generally have normal immune system function. The vaccine candidate, EP-2101, will include proprietary, native epitopes...
- IDM Presents Results of Its Phase I Trial of Its Collidem(R) Dendritic Cell...
- Press release article from: PR Newswire January 30, 2006 700+ words
...900 new colorectal cancer cases were...Collidem cancer vaccine candidate used in this...Phase I in colorectal cancer. IDM Pharma...colorectal vaccine candidate and the possible...treating colorectal cancer. Actual...
- igeneon Initiates Further Pivotal Phase III Clinical Trials With IGN101 Cancer...
- Press release article from: PR Newswire November 11, 2003 700+ words
...with its cancer vaccine candidate IGN101. The first...study in metastatic colorectal cancer, which will include...Austrian Breast & Colorectal Cancer Study Group (ABCSG...are diagnosed with colorectal cancer, which is the second...applicable cancer vaccine ...
- ImClone Systems receives European Patent Allowance For Colorectal Cancer...
- Press release article from: Business Wire February 6, 1996 700+ words
...European patent for the Company's colorectal cancer vaccine, 105AD7. 105AD7 is a human...can target and potentially destroy colorectal cancer cells. No toxicity related to the...investigating an additional cancer vaccine candidate, BEC-2, that targets a specific...
- Epimmune Receives FDA Clearance to Initiate Lung and Colorectal Cancer Vaccine...
- Press release article from: PR Newswire January 13, 2003 700+ words
...epitope vaccine in lung and colorectal cancer patients. Two separate Phase...immune system function. The vaccine candidate includes proprietary, native...clinical trials for lung and colorectal cancer, the Company's ability...
- FDA clears initiation of lung, colorectal cancer vaccine trials.
- Newspaper article from: Biotech Week February 5, 2003 700+ words
...2101 therapeutic, multi-epitope vaccine in lung and colorectal cancer patients. Two separate phase I/II trials will be initiated...patients generally have normal immune system function. The vaccine candidate includes proprietary, native epitopes as well as a number...
- Colorectal cancer: an overview of the epidemiology, risk factors, symptoms, and...
- Magazine article from: MedSurg Nursing Bazensky, Ivy Shoobridge-Moran, Candice Yoder, Linda H. February 1, 2007 700+ words
...concerning which individuals develop colorectal cancer (see Table 1). The purpose of...implications for this type of cancer. Colorectal cancer is the second leading cause of cancer...mortality rate is decreasing for colorectal cancer in both men and women. In the United...
Source: HighBeam Research, IND application filed for lung and colorectal cancer vaccine...